Safety and activity of lenalidomide and rituximab in untreated indolent lymphoma: an open-label, phase 2 trial. (Record no. 24394655)

MARC details
000 -LEADER
fixed length control field 02313 a2200685 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517003950.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201502s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1474-5488
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/S1470-2045(14)70455-3
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Fowler, Nathan H
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20150223
245 00 - TITLE STATEMENT
Title Safety and activity of lenalidomide and rituximab in untreated indolent lymphoma: an open-label, phase 2 trial.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. The Lancet. Oncology
Date of publication, distribution, etc. Nov 2014
300 ## - PHYSICAL DESCRIPTION
Extent 1311-8 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged, 80 and over
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Monoclonal, Murine-Derived
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Combined Chemotherapy Protocols
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Disease-Free Survival
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Administration Schedule
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lenalidomide
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lymphoma, Follicular
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lymphoma, Non-Hodgkin
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neoplasm Recurrence, Local
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neoplasm Staging
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Rituximab
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Thalidomide
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Davis, R Eric
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Rawal, Seema
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Nastoupil, Loretta
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hagemeister, Fredrick B
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name McLaughlin, Peter
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kwak, Larry W
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Romaguera, Jorge E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Fanale, Michelle A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Fayad, Luis E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Westin, Jason R
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Shah, Jatin
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Orlowski, Robert Z
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Wang, Michael
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Turturro, Francesco
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Oki, Yasuhiro
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Claret, Linda C
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Feng, Lei
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Baladandayuthapani, Veerabhadran
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Muzzafar, Tariq
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Tsai, Kenneth Y
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Samaniego, Felipe
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Neelapu, Sattva S
773 0# - HOST ITEM ENTRY
Title The Lancet. Oncology
Related parts vol. 15
-- no. 12
-- p. 1311-8
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/S1470-2045(14)70455-3">https://doi.org/10.1016/S1470-2045(14)70455-3</a>
Public note Available from publisher's website

No items available.